SeraCare posts $379,795 net operating loss for July

By Jennifer Lanning Drey

Eugene, Ore., Aug. 29 - SeraCare Life Sciences, Inc. reported a net operating loss of $379,795 for July on $2.8 million in sales, according to its monthly operating report filed Tuesday with the U.S. Bankruptcy Court for the Southern District of California.

The company reported $76,219 income from operations for June on $4.7 million in sales.

The net loss for July was $1.4 million, compared with $129,473 June net income.

Cash and cash equivalents on July 31 were $18.68 million, compared with $18.91 million on June 30.

SeraCare, an Oceanside, Calif., manufacturer and provider of biological products and services to diagnostic, therapeutic, drug discovery and research organizations, filed for bankruptcy on March 22. Its Chapter 11 case number is 06-00510.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.